- Home
- NVCR vs GIII Comparison
NVCR vs GIII Comparison
Compare NVCR & GIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- GIII
- Stock Information
- Founded
- NVCR 2000
- GIII 1956
- Country
- NVCR Switzerland
- GIII United States
- Employees
- NVCR N/A
- GIII N/A
- Industry
- NVCR Medical/Dental Instruments
- GIII Apparel
- Sector
- NVCR Health Care
- GIII Consumer Discretionary
- Exchange
- NVCR Nasdaq
- GIII Nasdaq
- Market Cap
- NVCR 1.4B
- GIII 1.2B
- IPO Year
- NVCR 2015
- GIII 1989
- Fundamental
- Price
- NVCR $13.77
- GIII $28.28
- Analyst Decision
- NVCR Buy
- GIII Hold
- Analyst Count
- NVCR 7
- GIII 5
- Target Price
- NVCR $28.79
- GIII $28.40
- AVG Volume (30 Days)
- NVCR 1.6M
- GIII 375.4K
- Earning Date
- NVCR 10-30-2025
- GIII 12-09-2025
- Dividend Yield
- NVCR N/A
- GIII N/A
- EPS Growth
- NVCR N/A
- GIII 0.24
- EPS
- NVCR N/A
- GIII 4.02
- Revenue
- NVCR $630,160,000.00
- GIII $3,123,169,000.00
- Revenue This Year
- NVCR $6.68
- GIII N/A
- Revenue Next Year
- NVCR $7.01
- GIII N/A
- P/E Ratio
- NVCR N/A
- GIII $7.08
- Revenue Growth
- NVCR 14.58
- GIII 1.19
- 52 Week Low
- NVCR $10.87
- GIII $20.33
- 52 Week High
- NVCR $34.13
- GIII $36.18
- Technical
- Relative Strength Index (RSI)
- NVCR 51.39
- GIII 61.70
- Support Level
- NVCR $13.57
- GIII $27.01
- Resistance Level
- NVCR $14.58
- GIII $28.59
- Average True Range (ATR)
- NVCR 0.64
- GIII 0.92
- MACD
- NVCR -0.05
- GIII 0.17
- Stochastic Oscillator
- NVCR 49.59
- GIII 92.80
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About GIII G-III Apparel Group LTD.
G-III Apparel Group Ltd is a textile company. It makes a wide range of apparel, footwear, and accessories that it sells under its own brands, licensed brands, and private-label brands. G-III has a substantial portfolio for licensed and proprietary brands, anchored by five global power brands: DKNY, Donna Karan, Calvin Klein, Tommy Hilfiger, and Karl Lagerfeld. The company has two reportable operations: Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, as well as sales of products under its own brands and private label brands. The retail operations segment consists of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives majority of its revenues from Wholesale operations.